BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa - Omicron - within two weeks to help determine whether its vaccine produced with partner Pfizer Inc would have to be reworked.

WATCH MORE: https://thestartv.com/c/news
SUBSCRIBE: https://cutt.ly/TheStar
LIKE: https://fb.com/TheStarOnline